PD-L1 expression and CD274 gene alteration in triple-negative breast cancer: implication for prognostic biomarker

PURPOSE: To estimate the therapeutic potential of PD-L1 inhibition in breast cancer, we evaluated the prevalence and significance of PD-L1 protein expression with a validated antibody and CD274 gene alternation in a large cohort of triple negative breast cancer (TNBC) and correlated with clinicopath...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Springerplus
Autors principals: Guo, Lei, Li, Wenbin, Zhu, Xinxin, Ling, Yun, Qiu, Tian, Dong, Lin, Fang, Yi, Yang, Hongying, Ying, Jianming
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2016
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4916110/
https://ncbi.nlm.nih.gov/pubmed/27390646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-016-2513-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars